"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms ...
The company said the FDA approved Icotyde to treat moderate to severe plaque psoriasis in adults and pediatric patients 12 ...
Psoriasis is a skin condition that causes the formation of thick, scaly patches on the body. It’s commonly found on the elbows, knees or scalp but can occur nearly anywhere on the skin. Cold weather ...
"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...
Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...
A high proportion of patients with moderate to severe plaque psoriasis achieved long-term on-treatment remission for 3 years with bimekizumab, according to a poster presentation at Winter Clinical ...
In his late teens, two significant things happened in Brandon Catapane’s life. He shared with his family that he was gay. And at the same time, the areas of dry skin on his scalp that had caused ...
Even as the prevalence of psoriasis increases around the world, with the highest proportions found in white populations, there is apparently a greater burden of disease among populations with skin of ...
Pharmaceutical Technology on MSN
J&J wins FDA approval for Icotyde to enter psoriasis pill market
J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results